[Federal Register Volume 62, Number 189 (Tuesday, September 30, 1997)]
[Notices]
[Pages 51111-51112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-25834]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates:
      8:30 a.m.-4:45 p.m., October 22, 1997.
      8:30 a.m.-1:15 p.m., October 23, 1997.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. Sec. 1396s, the Committee is mandated to establish 
and periodically review and, as appropriate, revise the list of 
vaccines for administration to vaccine-eligible children through the 
Vaccines for Children (VFC) program, along with schedules regarding 
the Page 2 appropriate periodicity, dosage, and contraindications 
applicable to the vaccines.
    Matters to be Discussed: Under the authority of 42 U.S.C. 
Sec. 1396s, the Committee will consider revision of the ACIP VFC 
program resolution for Adolescent Hepatitis B immunization.

    Other topics include: updates on the National Vaccine Program, the 
Vaccine Injury Compensation Program, and the influenza pandemic 
preparedness plan; discussions on rabies postexposure prophylaxis, the 
recommendations on the use of Rotashield (Rotavirus 
vaccine) as part of the routine childhood immunization schedule, ACIP 
guidelines on combination vaccines, the harmonized immunization 
schedule, public health laboratory capacity for vaccine-preventable 
disease surveillance, immunization of bone marrow transplant (BMT) 
recipients, the report from work group on algorithms for immunization 
registries, and the isolation of influenza type A(H5N1) in Hong Kong. 
There will also be presentations on the efficacy of live attenuated 
influenza vaccine and the Swedish acellular pertussis mass vaccination 
project. Other matters of relevance among the Committee's objectives 
may be discussed.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: Gloria A. Kovach, Committee

[[Page 51112]]

Management Specialist, CDC, 1600 Clifton Road, NE, M/S D50, Atlanta, 
Georgia 30333, telephone 404/639-7250.

    Dated: September 24, 1997.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-25834 Filed 9-29-97; 8:45 am]
BILLING CODE 4163-18-P